Fleebs-Logo
Details werden geladen...

EPIK Biosciences Launches to Pioneer Ketamine-Powered Psychedelic Therapies to Transform Treatment of Mental Health, Pain, and Addiction | The Manila Times

Advancing synergistic combination medicines, non-opioid solutions for chronic pain,neuropsychiatric disorders, and substance use disorders using patient-friendly delivery methods.

Ähnliche Seiten

https://www.manilatimes.net/2026/04/16/tmt-newswire/globenewswire/nula-therapeutics-launches-with-up-to-20-million-arpa-h-award-to-advance-a-new-class-of-medicines-targeting-the-nuclear-envelope-of-cells/2321817

Nula Therapeutics Launches with up to $20 Million ARPA-H Award to Advance a New Class of Medicines Targeting the Nuclear Envelope of Cells | The Manila Times

https://www.manilatimes.net/2026/04/16/tmt-newswire/globenewswire/nula-therapeutics-launches-with-up-to-20-million-arpa-h-award-to-advance-a-new-class-of-medicines-targeting-the-nuclear-envelope-of-cells/2321817